Latest Insider Transactions at Moderna, Inc. (MRNA)
This section provides a real-time view of insider transactions for Moderna, Inc. (MRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moderna, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moderna, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 22
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|
|
Jul 22
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$711,000
$79.61 P/Share
|
|
Jul 20
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-39.21%
|
$1,680,000
$84.49 P/Share
|
|
Jul 20
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Jul 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
6,326
-0.01%
|
$531,384
$84.33 P/Share
|
|
Jul 17
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.2%
|
$983,094
$89.45 P/Share
|
|
Jul 16
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$800,000
$80.39 P/Share
|
|
Jul 15
2020
|
Elizabeth G Nabel Director |
SELL
Open market or private sale
|
Direct |
73,975
-100.0%
|
$6,435,825
$87.84 P/Share
|
|
Jul 15
2020
|
Elizabeth G Nabel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
59,631
+22.36%
|
$1,013,727
$17.51 P/Share
|
|
Jul 15
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|
|
Jul 15
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$783,000
$87.84 P/Share
|
|
Jul 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.04%
|
$710,000
$71.07 P/Share
|
|
Jul 13
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.5%
|
$0
$0.99 P/Share
|
|
Jul 13
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-33.72%
|
$1,420,000
$71.08 P/Share
|
|
Jul 13
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Jul 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
20,281
-0.56%
|
$1,277,703
$63.98 P/Share
|
|
Jul 09
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$620,000
$62.04 P/Share
|
|
Jul 08
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|
|
Jul 08
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-69.79%
|
$1,220,000
$61.26 P/Share
|
|
Jul 08
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Jul 07
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
62,688
-54.66%
|
$3,698,592
$59.55 P/Share
|
|
Jul 07
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,688
+34.62%
|
$1,003,008
$16.84 P/Share
|
|
Jul 06
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.5%
|
$580,000
$58.48 P/Share
|
|
Jul 06
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.5%
|
$0
$0.99 P/Share
|
|
Jul 06
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.52%
|
$651,714
$59.38 P/Share
|
|
Jul 02
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$590,000
$59.94 P/Share
|
|
Jul 02
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.5%
|
$590,000
$59.94 P/Share
|
|
Jul 02
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.5%
|
$0
$0.99 P/Share
|
|
Jul 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|
|
Jul 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
9,344
-0.1%
|
$579,328
$62.92 P/Share
|
|
Jul 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$558,000
$62.92 P/Share
|
|
Jun 30
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
39,752
-50.44%
|
$2,504,376
$63.65 P/Share
|
|
Jun 30
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,752
+39.11%
|
$755,288
$19.15 P/Share
|
|
Jun 26
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.68%
|
$662,760
$60.81 P/Share
|
|
Jun 25
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$670,000
$67.0 P/Share
|
|
Jun 24
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|
|
Jun 24
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$567,000
$63.25 P/Share
|
|
Jun 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$325,000
$65.09 P/Share
|
|
Jun 23
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$320,000
$64.16 P/Share
|
|
Jun 23
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
39,752
-83.6%
|
$2,544,128
$64.16 P/Share
|
|
Jun 23
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,752
+39.11%
|
$755,288
$19.15 P/Share
|
|
Jun 22
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
4,521
-0.05%
|
$293,865
$65.92 P/Share
|
|
Jun 19
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.0%
|
$717,990
$65.04 P/Share
|
|
Jun 18
2020
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
64,000
-98.95%
|
$4,032,000
$63.03 P/Share
|
|
Jun 18
2020
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
64,000
+49.74%
|
$896,000
$14.85 P/Share
|
|
Jun 16
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
39,752
-81.31%
|
$2,544,128
$64.94 P/Share
|
|
Jun 16
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,752
+39.11%
|
$755,288
$19.15 P/Share
|
|
Jun 15
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$325,000
$65.35 P/Share
|
|
Jun 12
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.66%
|
$684,852
$62.03 P/Share
|
|
Jun 12
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$305,000
$61.96 P/Share
|